Trichosporon Asahii Superinfection in a Patient with COVID-19

• Published in: Ankara Ueniversitesi Tip Fakültesi mecmuasi Vol. 75; no. 3; pp. 472 - 474
• Main Authors: Budak, Serdar, Yılmaz, Gülseren, Kaya, Ebru, Altunbay, Ramazan Ahmet, Bayer, Tuğçe, Cinel, Gizem, Kahraman, Emirhan, Kölgeli, Okan, Şahin, Ayça Sultan, Topal, Ümmühan, Salihoğlu, Ziya
• Format: Journal Article
• Language: English; Turkish
• Published: Ankara Galenos Publishing House 18-10-2022
• Subjects: Antibiotics; Case reports; Conflicts of interest; Coronaviruses; COVID-19; Epidemiology; Fungal infections; Hospitalization; Mortality; Pathogens; Patients; Pneumonia; Respiratory distress syndrome; Risk factors; Steroids; China
• ISSN: 1307-5608; 0365-8104; 1307-5608
• DOI: 10.4274/atfm.galenos.2022.64325

The use of immunosuppressant drugs to treat immunological storms in patients with severe coronavirus disease-2019 (COVID-19) infection has increased considerations concerning fungal infections. In this patient subset with immune compromise, Trichosporon Asahii (T. asahii) may cause significant mortality. In this case report, a 60-year-old patient who developed T. Asahii fungemia while being followed in the intensive care unit due to COVID-19 pneumonia was presented.